Sanofi Reports Success in Trial for Rare Infant Genetic Disease Treatment

Paris, Tuesday, 30 June 2026.
Sanofi’s latest clinical trial successfully kept infants with a rare, fatal genetic disease alive and ventilator-free for a year, proving highly effective with no serious side effects.